These resources are offered to clinicians for use with their patients with hematologic malignancies and their families, when discussing biosimilars as treatment options. They offer a wealth of information about what biosimilars are, how they work, and their safety and efficacy. The resources are available in both English and Spanish.
|
||||||
|
Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Pfizer, Inc.